Joseph, N., Parikh, R., Allada, S., Gupta, V., Hofmeister, C., Shah, N., Kaufman, J., Lonial, S., Nooka, A. (2025). Real world evidence comparing idecabtagene vicleucel (Ide-cel, Abecma) versus ciltacabtagene autoleucel (Cilta-cel, Carvykti) chimeric antigen receptor T-cell (CART) therapy among patients with Relapsed/Refractory multiple myeloma (RRMM). Blood. https://doi.org/10.1182/blood-2025-2301